Study of KDM1A and VEGF changes as the responsible genes in the angiogenesis of breast cancer.

N HashemiM KavousiF Jamshidian

Published in: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti (2024)

The results of this experiment demonstrated that the treatment of breast cancer cells with tamoxifen reduces the expression of VEGF and KDM1A by increasing miR-329. The treatment therefore reduces angiogenesis, and thus its anti-tumor effects are applied.

Keyphrases

vascular endothelial growth factor
endothelial cells
breast cancer cells
cell proliferation
poor prognosis
long non coding rna
genome wide
wound healing
young adults
combination therapy
estrogen receptor